Broker Ratings

Omega Healthcare Investors, Inc. Share Price Target ‘$32.53’, now 12.2% Upside Potential

Omega Healthcare Investors, Inc. which can be found using ticker (OHI) have now 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between $37.00 and $28.00 and has a mean share price target at $32.53. (at the time of writing). Now with the previous closing price of $29.00 this now indicates there is a potential upside of 12.2%. There is a 50 day moving average of $30.59 while the 200 day moving average is $31.03. The market capitalization for the company is 7.44B. The current share price for the company is: $29.52 USD

The potential market cap would be $8,343,458,369 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 30.12, revenue per share of $3.60 and a 2.36% return on assets.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company’s core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company’s portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search